248 related articles for article (PubMed ID: 34333522)
1. Fibrillar α-synuclein induces neurotoxic astrocyte activation via RIP kinase signaling and NF-κB.
Chou TW; Chang NP; Krishnagiri M; Patel AP; Lindman M; Angel JP; Kung PL; Atkins C; Daniels BP
Cell Death Dis; 2021 Jul; 12(8):756. PubMed ID: 34333522
[TBL] [Abstract][Full Text] [Related]
2. α-Synuclein oligomers potentiate neuroinflammatory NF-κB activity and induce Ca
Leandrou E; Chalatsa I; Anagnostou D; Machalia C; Semitekolou M; Filippa V; Makridakis M; Vlahou A; Anastasiadou E; Vekrellis K; Emmanouilidou E
Transl Neurodegener; 2024 Feb; 13(1):11. PubMed ID: 38378800
[TBL] [Abstract][Full Text] [Related]
3. Aggregated alpha-synuclein transcriptionally activates pro-inflammatory canonical and non-canonical NF-κB signaling pathways in peripheral monocytic cells.
Bearoff F; Dhavale D; Kotzbauer P; Kortagere S
Mol Immunol; 2023 Feb; 154():1-10. PubMed ID: 36571978
[TBL] [Abstract][Full Text] [Related]
4. Astrocyte inflammatory signaling mediates α-synuclein aggregation and dopaminergic neuronal loss following viral encephalitis.
Bantle CM; Rocha SM; French CT; Phillips AT; Tran K; Olson KE; Bass TA; Aboellail T; Smeyne RJ; Tjalkens RB
Exp Neurol; 2021 Dec; 346():113845. PubMed ID: 34454938
[TBL] [Abstract][Full Text] [Related]
5. Activating transcription factor-4 promotes neuronal death induced by Parkinson's disease neurotoxins and α-synuclein aggregates.
Demmings MD; Tennyson EC; Petroff GN; Tarnowski-Garner HE; Cregan SP
Cell Death Differ; 2021 May; 28(5):1627-1643. PubMed ID: 33277577
[TBL] [Abstract][Full Text] [Related]
6. α-Synuclein disrupts the anti-inflammatory role of Drd2 via interfering β-arrestin2-TAB1 interaction in astrocytes.
Du RH; Zhou Y; Xia ML; Lu M; Ding JH; Hu G
J Neuroinflammation; 2018 Sep; 15(1):258. PubMed ID: 30200997
[TBL] [Abstract][Full Text] [Related]
7. Neuronal DAMPs exacerbate neurodegeneration via astrocytic RIPK3 signaling.
Chang NP; DaPrano EM; Lindman M; Estevez I; Chou TW; Evans WR; Nissenbaum M; McCourt M; Alzate D; Atkins C; Kusnecov AW; Huda R; Daniels BP
JCI Insight; 2024 May; 9(11):. PubMed ID: 38713518
[TBL] [Abstract][Full Text] [Related]
8. Mutations in LRRK2 impair NF-κB pathway in iPSC-derived neurons.
López de Maturana R; Lang V; Zubiarrain A; Sousa A; Vázquez N; Gorostidi A; Águila J; López de Munain A; Rodríguez M; Sánchez-Pernaute R
J Neuroinflammation; 2016 Nov; 13(1):295. PubMed ID: 27863501
[TBL] [Abstract][Full Text] [Related]
9. Protein Kinase-Mediated Decision Between the Life and Death.
Engin A
Adv Exp Med Biol; 2021; 1275():1-33. PubMed ID: 33539010
[TBL] [Abstract][Full Text] [Related]
10. The interplay of IKK, NF-κB and RIPK1 signaling in the regulation of cell death, tissue homeostasis and inflammation.
Kondylis V; Kumari S; Vlantis K; Pasparakis M
Immunol Rev; 2017 May; 277(1):113-127. PubMed ID: 28462531
[TBL] [Abstract][Full Text] [Related]
11. RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition.
Dondelinger Y; Aguileta MA; Goossens V; Dubuisson C; Grootjans S; Dejardin E; Vandenabeele P; Bertrand MJ
Cell Death Differ; 2013 Oct; 20(10):1381-92. PubMed ID: 23892367
[TBL] [Abstract][Full Text] [Related]
12. α-Synuclein overexpression enhances manganese-induced neurotoxicity through the NF-κB-mediated pathway.
Prabhakaran K; Chapman GD; Gunasekar PG
Toxicol Mech Methods; 2011 Jul; 21(6):435-43. PubMed ID: 21417633
[TBL] [Abstract][Full Text] [Related]
13.
Karunakaran D; Nguyen MA; Geoffrion M; Vreeken D; Lister Z; Cheng HS; Otte N; Essebier P; Wyatt H; Kandiah JW; Jung R; Alenghat FJ; Mompeon A; Lee R; Pan C; Gordon E; Rasheed A; Lusis AJ; Liu P; Matic LP; Hedin U; Fish JE; Guo L; Kolodgie F; Virmani R; van Gils JM; Rayner KJ
Circulation; 2021 Jan; 143(2):163-177. PubMed ID: 33222501
[TBL] [Abstract][Full Text] [Related]
14. NF-κB inhibition in keratinocytes causes RIPK1-mediated necroptosis and skin inflammation.
Kumari S; Van TM; Preukschat D; Schuenke H; Basic M; Bleich A; Klein U; Pasparakis M
Life Sci Alliance; 2021 Jun; 4(6):. PubMed ID: 33858959
[TBL] [Abstract][Full Text] [Related]
15. α-synuclein oligomers enhance astrocyte-induced synapse formation through TGF-β1 signaling in a Parkinson's disease model.
Diniz LP; Matias I; Araujo APB; Garcia MN; Barros-Aragão FGQ; Alves-Leon SV; de Souza JM; Foguel D; Figueiredo CP; Braga C; Romão L; Gomes FCA
J Neurochem; 2019 Jul; 150(2):138-157. PubMed ID: 31009074
[TBL] [Abstract][Full Text] [Related]
16. Microglia and astrocyte activation is region-dependent in the α-synuclein mouse model of Parkinson's disease.
Basurco L; Abellanas MA; Ayerra L; Conde E; Vinueza-Gavilanes R; Luquin E; Vales A; Vilas A; Martin-Uriz PS; Tamayo I; Alonso MM; Hernaez M; Gonzalez-Aseguinolaza G; Clavero P; Mengual E; Arrasate M; Hervás-Stubbs S; Aymerich MS
Glia; 2023 Mar; 71(3):571-587. PubMed ID: 36353934
[TBL] [Abstract][Full Text] [Related]
17. Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease.
di Domenico A; Carola G; Calatayud C; Pons-Espinal M; Muñoz JP; Richaud-Patin Y; Fernandez-Carasa I; Gut M; Faella A; Parameswaran J; Soriano J; Ferrer I; Tolosa E; Zorzano A; Cuervo AM; Raya A; Consiglio A
Stem Cell Reports; 2019 Feb; 12(2):213-229. PubMed ID: 30639209
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of RIPK1 Markedly Exacerbates Murine Immune-Mediated Liver Injury through Massive Apoptosis of Hepatocytes, Independent of Necroptosis and Inhibition of NF-κB.
Suda J; Dara L; Yang L; Aghajan M; Song Y; Kaplowitz N; Liu ZX
J Immunol; 2016 Oct; 197(8):3120-3129. PubMed ID: 27605011
[TBL] [Abstract][Full Text] [Related]
19. Glucocerebrosidase Activity Modulates Neuronal Susceptibility to Pathological α-Synuclein Insult.
Henderson MX; Sedor S; McGeary I; Cornblath EJ; Peng C; Riddle DM; Li HL; Zhang B; Brown HJ; Olufemi MF; Bassett DS; Trojanowski JQ; Lee VMY
Neuron; 2020 Mar; 105(5):822-836.e7. PubMed ID: 31899072
[TBL] [Abstract][Full Text] [Related]
20. A characterization of Gaucher iPS-derived astrocytes: Potential implications for Parkinson's disease.
Aflaki E; Stubblefield BK; McGlinchey RP; McMahon B; Ory DS; Sidransky E
Neurobiol Dis; 2020 Feb; 134():104647. PubMed ID: 31669751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
